Coeptis Therapeutics Holdings, Inc. (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, today ...
On Nov. 29, 1963, just seven days after he became President of the U.S. because of the assassination of John F. Kennedy, Lyndon Johnson issued Executive Order No. 11,130, setting up a blue-ribbon ...